Discuss a partnershipPartners
Expand radionuclide production at your existing facility
EnVoy‑LAB helps qualified radioisotope producers add high‑yield Ac‑225 and Pb‑212 production using existing 19–30 MeV proton cyclotrons and radiochemical infrastructure. You operate the process in your facility. We provide the target technology, implementation expertise, and continuing support needed to bring it online.
Ac‑225 and Pb‑212 remain EnVoy’s primary commercial focus, but for partners with cyclotrons operating at energies as low as 16 MeV, the same fast‑neutron platform may also support additional medically important radionuclides based on facility capabilities and production priorities.
By using your cyclotrons, hot cells, trained personnel, regulatory authorizations, and distribution networks already in place, EnVoy can help you expand radioisotope capacity faster than would be possible otherwise. A distributed production network also reduces dependence on individual sites and brings production closer to radiopharmaceutical developers, an important advantage for short‑lived radioisotopes such as Pb‑212. The EnVoy platform is capable of augmenting your existing production capabilities, and even provides a drop‑in replacement for many competing radium‑based production routes, with integration into your existing processing infrastructure.
Explore a production partnership
Facility fit
Is your facility a fit?
Your facility may be a strong candidate if you:
- Operate a 19–30 MeV proton cyclotron for Ac‑225 and Pb‑212 production
- Or operate a proton cyclotron at 16 MeV or above and wish to explore other neutron‑produced radionuclides
- Have hot cells and radiochemistry capabilities appropriate for the planned radioisotopes
- Employ trained personnel to operate the above and maintain the necessary regulatory authorizations
- Have access to the appropriate source material, including Ra‑226 for Ac‑225 and Pb‑212 production
- Maintain established quality‑control, packaging, and distribution systems
Not every element needs to be finalized before beginning a conversation. EnVoy can assess your existing capabilities, identify gaps, and determine what would be required to deploy the platform.
EnVoy support
What you receive from EnVoy
We adapt the platform to your facility and production objectives. EnVoy provides:
- A target configured and optimized for your cyclotron, beamline, production goals, and radium inventory
- Target fabrication and integration support
- Operating specifications and procedures
- Commissioning, training, and technology transfer
- Yield optimization and troubleshooting
- Continuing scientific and engineering support
Your team operates the irradiation and chemical‑separation processes and manages quality control, regulatory compliance, packaging, and distribution. EnVoy remains engaged to support reliable production, continued optimization, and future expansion of your production portfolio.
Deployment
From facility assessment to production
- 01
Assess your facility
We review your cyclotron, beamline, shielding, hot cells, operating schedule, radium inventory, and desired radioisotope output.
- 02
Configure the platform
We adapt the target and operating approach to your specific equipment and production objectives rather than asking you to conform to a generic system.
- 03
Install and commission
EnVoy supports target installation, initial irradiations, yield validation, radium recovery, process qualification, and operator training.
- 04
Begin routine production
Your team runs the process within your existing operations. EnVoy provides continuing technical support and applies knowledge gained across its partner network.
Depending on facility readiness and cyclotron configuration, a qualified partner could begin initial production within four to six months of engagement.
